Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 20,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 20,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 44,215 | 38,509 | 29,986 | 29,496 | 27,108 |
| Operating Income | -24,215 | -38,509 | -29,986 | -29,496 | -27,108 |
| Other Income | 4,358 | 4,746 | 3,061 | 2,764 | 3,045 |
| Pre-tax Income | -19,857 | -33,763 | -26,925 | -26,732 | -24,063 |
| Net Income Continuous | -19,857 | -33,763 | -26,925 | -26,732 | -24,063 |
| Net Income | $-19,857 | $-33,763 | $-26,925 | $-26,732 | $-24,063 |
| EPS Basic Total Ops | -0.42 | -0.72 | -0.71 | -0.75 | -0.68 |
| EPS Basic Continuous Ops | -0.42 | -0.72 | -0.71 | -0.75 | -0.68 |
| EPS Diluted Total Ops | -0.42 | -0.72 | -0.71 | -0.75 | -0.68 |
| EPS Diluted Continuous Ops | -0.42 | -0.72 | -0.71 | -0.75 | -0.68 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.72 | -0.71 | -0.75 | -0.68 |
| EBITDA(a) | $-24,352 | $-39,316 | $-29,526 | $-29,336 | $-27,300 |